Related Experiment Videos
[Thrombolytic therapy in acute myocardial infarctions]
M A Schei1, J O Hessen, O Kildahl-Andersen
1Institutt for samfunnsmedisin, Universitetet i Tromsø.
Summary
This study found significant delays in administering thrombolytic treatment for acute myocardial infarction patients. Improving treatment protocols is crucial for better patient outcomes in Norwegian hospitals.
Area of Science:
- Cardiology
- Public Health
Background:
- Acute myocardial infarction (AMI) management requires timely intervention.
- Thrombolytic therapy is a critical treatment for AMI.
Purpose of the Study:
- To analyze the administration of thrombolytic treatment in AMI patients at Harstad District Hospital in 1995.
- To identify delays and areas for improvement in thrombolytic therapy protocols.
Main Methods:
- Retrospective analysis of 170 AMI patients treated in 1995.
- Data collection on treatment received, timing of administration, and patient admission times.
Main Results:
- 24% of AMI patients received thrombolytic treatment.
- Thrombolytics were withheld in 15% of cases without contraindications.
- Mean delay from admission to thrombolytic administration was 2 hours 18 minutes; 7 hours from symptom onset.
- 54% of patients admitted within 6 hours, 73% within 12 hours.
Conclusions:
- In-hospital delays in thrombolytic administration for AMI are significant.
- There is substantial potential for improving the utilization and timeliness of thrombolytic treatment.
- The study prompted significant changes in hospital treatment routines.